Cogan’s syndrome is a rare autoimmune disease that causes inflammation in two specific places: the eyes and the inner ears. It typically shows up as eye redness and pain alongside sudden hearing loss, ringing in the ears, and severe dizziness. Without prompt treatment, hearing loss can progress to complete deafness in as little as one to three months.
The condition is driven by the immune system mistakenly attacking healthy tissue. Biopsies of affected corneal and inner ear tissue show infiltration by immune cells, pointing to a cell-mediated autoimmune reaction rather than an infection. Cogan’s syndrome has no single definitive lab test. Diagnosis is clinical, based on the combination of inner ear symptoms, inflammatory eye disease, and the exclusion of other causes, particularly syphilis, which can produce a similar pattern.
How It Affects the Eyes
The hallmark eye problem in Cogan’s syndrome is interstitial keratitis, a type of inflammation that affects the deeper layers of the cornea. This causes eye redness, pain, sensitivity to light, and blurred vision. In the “typical” form of the disease, eye symptoms appear first, and the ear problems follow within two years.
An “atypical” form also exists, where the eye inflammation takes other forms or the timing between eye and ear symptoms stretches beyond two years. In some atypical cases, ear symptoms may actually appear before any eye involvement, which can make the diagnosis harder to pin down early on.
Inner Ear Symptoms and Hearing Loss
The inner ear involvement in Cogan’s syndrome closely mimics Ménière’s disease. Symptoms include intense vertigo with nausea and vomiting, ringing in the ears (tinnitus), and fluctuating hearing loss that affects both sides. Some people also experience involuntary eye movements and problems with balance and coordination.
The vestibular system, which controls balance, is usually the first part of the inner ear to be affected. The cochlea, responsible for hearing, follows within days or weeks. Once hearing loss sets in, it tends to worsen rapidly. Progressive sensorineural hearing loss can lead to deafness within one to three months if the inflammation is not controlled. This aggressive timeline is one of the reasons early recognition matters so much.
Systemic Complications
Cogan’s syndrome can extend beyond the eyes and ears. Some patients develop inflammation of blood vessels (vasculitis), including inflammation of the aorta, the body’s largest artery. This systemic involvement can affect multiple organ systems and represents the most serious potential complication of the disease. Fever, fatigue, weight loss, and joint pain may also accompany flares.
How It Is Diagnosed
There is no single blood test or imaging scan that confirms Cogan’s syndrome. CT and MRI scans of the head are often normal, though MRI with contrast dye occasionally reveals abnormalities in the inner ear structures, such as calcification or narrowing of the cochlea and vestibular labyrinth. Some researchers have identified antibodies against a specific protein (heat shock protein 70) in the blood of affected patients, which may serve as a helpful marker, but this test is not yet standard.
The diagnosis rests on three pillars: confirmed sensorineural hearing loss, inflammatory eye disease, and ruling out infections or other conditions that could explain both. Syphilis testing is a mandatory part of the workup because syphilitic interstitial keratitis looks nearly identical on exam.
Treatment
The first line of treatment is high-dose corticosteroids to suppress the immune system’s attack on the eyes and inner ear. For eye inflammation, steroid eye drops are often enough. For hearing loss and vestibular symptoms, oral or intravenous steroids are typically needed, and starting them early gives the best chance of preserving hearing.
When the disease relapses or when patients cannot taper off steroids without symptoms returning, stronger immunosuppressive medications come into play. These have modest effectiveness on their own but can help reduce the steroid dose needed to keep symptoms controlled. In cases that resist these conventional options, biologic therapies that target specific parts of the immune system have shown promise. One such biologic, infliximab, has been the most widely used in Cogan’s syndrome and has led to hearing improvement in roughly 89% of treated cases, while allowing 86% of patients to reduce their steroid use.
For ongoing balance problems that persist after the acute inflammation settles, vestibular therapy (a specialized form of physical therapy), antihistamines, or anti-anxiety medications can help manage chronic dizziness.
When Hearing Cannot Be Saved
For patients whose hearing loss becomes permanent despite medication, cochlear implants offer a highly effective solution. A long-term study of 12 implant recipients with Cogan’s syndrome found average word recognition scores of 91% at one year and 94% at five years after surgery, with sentence recognition reaching 96%. No patients in that study experienced serious complications.
Among the broader population of adults with Cogan’s syndrome who have received cochlear implants, nearly half had calcification of the cochlea, a known consequence of the disease that can make surgery more challenging. Surgeons have consistently found ways to work around this, either by tunneling through the calcified area or by placing the electrode in an alternate part of the inner ear. In children with the condition, cochlear implantation has also been performed successfully without complications.
Only about 8% of implant recipients experienced procedure-related complications, and roughly 12% had a flare of their Cogan’s syndrome shortly after surgery, most commonly a return of eye inflammation. Overall, cochlear implants are considered both safe and highly effective for Cogan’s syndrome patients with profound hearing loss, delivering excellent and stable results over many years of use.